Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07086742

Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate

Led by Pathway Medtech, LLC. · Updated on 2025-08-17

36

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

Sponsors

P

Pathway Medtech, LLC.

Lead Sponsor

H

Haku Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical study is to investigate a new medical device, the Smart Mask V1 System (herein 'Smart Mask'), and particularly its measurements of blood oxygen levels (SpO2) and pulse rate (PR) in healthy adults aged 18 to 65. More specifically, the study is directed at answering the following questions: * Can the Smart Mask accurately measure SpO2 levels compared to established reference devices (reference oximeters, blood gas) throughout the range of SpO2 \~ 70 - 100%? * Can the Smart Mask accurately measure PR during the same conditions? * Does skin pigmentation impact the accuracy of Smart Mask's measurements of SpO2 and PR. The following reference devices will be used in the study: * An FDA-cleared fingertip pulse oximeter (Nellcor Portable SpO2 Patient Monitoring System, PM10N) * A laboratory-grade CO-oximeter (Radiometer ABL90 FLEX) that analyzes oxygen saturation from blood samples. Study participants will: * Wear the Smart Mask on their face and a fingertip pulse oximeter while lying down * Breathe air with gradually reduced oxygen levels inside a specialized hypoxia room while being closely. * In a second phase of the study, have a catheter inserted into a wrist artery for blood sampling to directly measure oxygen levels with the CO-oximeter.

CONDITIONS

Official Title

Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy subjects with ASA health score of I or II
  • Subjects aged between 65 18 and 64 65 years
  • Subjects who have provided informed consent and are willing to comply with the study procedures
Not Eligible

You will not qualify if you...

  • Heavy smokers or individuals exposed to high levels of carbon monoxide resulting in elevated carboxyhemoglobin levels
  • Individuals with conditions that result in elevated methemoglobin levels
  • Individuals with hypoxia (SpO2 < 95% at 21% O2)
  • Severe claustrophobia
  • Subjects known with altitude sickness
  • Subjects who are obese (BMI 65 35 kg/m2)
  • Subjects with a known history of moderate to severe heart, lung, kidney or liver disease
  • Subjects diagnosed with moderate to severe asthma
  • Subjects with a hemoglobinopathy or history of anemia, e.g. sickle cell anemia, thalassemia, that in the investigator's opinion, would make them unsuitable for study participation
  • Subjects with any other serious systemic illness
  • Any injury, deformity, or abnormality at the sensor sites that, in the investigator's opinion, would interfere with the correct functioning of the test or reference devices
  • Subjects with a history of fainting or vasovagal response
  • Subjects with a history of sensitivity or allergy to local anesthetics or disinfectants if included in the IN study
  • Subjects diagnosed with Raynaud's disease
  • Subjects with unacceptable collateral circulation based on examination by the investigator
  • Subjects who are pregnant, lactating or trying to become pregnant
  • Subjects unable or unwilling to provide informed consent or comply with study procedures
  • Subjects with any other condition that, in the investigator's opinion, would make them unsuitable for the study
  • Subjects who refuse to remove nail polish from their index finger
  • Volunteers not willing to remove facial make-up

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Complementair Medisch Centrum (CMC) Europe

Genk, Belgium, 3600

Actively Recruiting

Loading map...

Research Team

R

Raf De Jongh, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate | DecenTrialz